Related Experiment Video

Updated: Feb 12, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

658

Prognostic value of selected risk scales in patients with end-stage heart failure

Wioletta Szczurek, Bożena Szyguła-Jurkiewicz1, Michał W Zakliczyński

  • 13rd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland. bjurkiewicz@sum.edu.pl.

Kardiologia Polska
|April 11, 2018
PubMed

Insights

The Model for End-stage Liver Disease eXcluding INR (MELD-XI) score better predicts one-year mortality in heart transplant candidates than the Heart Failure Survival Score (HFSS). The Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) scale showed comparable predictive value to HFSS.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Medical Informatics

Background:

  • Increasing orthotopic heart transplantation (OHT) waiting lists necessitate accurate patient risk stratification.
  • Identifying high-risk patients is crucial for efficient OHT resource allocation.

Purpose of the Study:

  • To assess the predictive accuracy of MELD-XI and MAGGIC scales for one-year mortality in OHT candidates.
  • To compare the prognostic performance of MELD-XI and MAGGIC against the HFSS.

Main Methods:

  • Retrospective review of 370 adult ambulatory patients awaiting OHT (2012-2016).
  • Evaluation of MELD-XI, MAGGIC, and HFSS scoring systems.
  • Analysis of one-year mortality rates and predictive performance using Area Under the Curve (AUC).

Main Results:

  • Overall one-year mortality was 27.6%.
  • MELD-XI demonstrated a higher AUC (0.812) compared to HFSS (0.781).
  • MAGGIC (AUC 0.771) showed comparable predictive value to HFSS.

Conclusions:

  • Elevated MELD-XI and MAGGIC scores, and lower HFSS scores, correlate with increased one-year mortality risk.
  • MELD-XI offers superior prognostic utility over HFSS for OHT candidates.
  • MELD-XI and MAGGIC scales are valuable tools for risk stratification in heart transplant evaluation.
Abstract

Keywords:
end-stage heart failureheart transplant waiting listprognostic scales

More Related Videos

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

6.3K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
951
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
360